Jianming Chen

Jianming Chen


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 November 2020 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
DCDuo Chen
Duo Chen
QZQing Zhang
Qing Zhang
WTWeiqi Tang
Weiqi Tang
ZHZhen Huang
Zhen Huang
GWGang Wang
Gang Wang
JZJisen Zhang
Jisen Zhang
Significance: We assembled one of the most contiguous genomes for the common goldfish and unveiled the genetic architecture of many well-known and anatomically interesting traits, owing to the sequencing of a large collection of goldfish varieties. The datasets that we have generated for candidate genes or genomic regions based on population genomics may help to elucidate the evolution of goldfish and goldfish varieties and may provide a resource for a wide range of studies with important implications for the use of goldfish as a model for vertebrate and fish genetics.

13 February 2018 in Marine Drugs
Verified
Journal Article
Open access
PDF file
WWWeiyi Wang
Weiyi Wang
YLYanyan Liao
Yanyan Liao
RCRuixuan Chen
Ruixuan Chen
YHYanping Hou
Yanping Hou
WKWenqian Ke
Wenqian Ke
Fang LiFang Li
Fang Li
Four novel compounds, chaephilone C (1), chaetoviridides A–C (2–4), were obtained from the culture of a deep sea derived fungus Chaetomium sp. NA-S01-R1, together with four known compounds—chaetoviridin A (5), chaetoviridine E (6), chaetomugilin D (7) and cochliodone A (8). Their structures, including absolute configurations, were assigned based on NMR, MS and time-dependent density functional theory (TD-DFT) ECD calculations. A plausible biogenetic pathway for compounds 1–3 was proposed. Compounds 2 and 3 exhibited antibacterial activities against Vibrio rotiferianus and Vibrio vulnificus. Compounds 1, 3 and 4 displayed similar anti-methicillin resistant Staphylococcus aureus (anti-MRSA) activities in comparison to chloramphenicol. Compound 2 showed the most potent cytotoxic activities towards the Hep G2 cell and compounds 1 and 3 demonstrated relatively stronger cytotoxic activities than the other compounds against the HeLa cell.

28 September 2015 in Oncogene
Verified
Journal Article
Open access
PDF file
ZLZ Li
Z Li
QHQ Hao
Q Hao
JLJ Luo
J Luo
JXJ Xiong
J Xiong
SZS Zhang
S Zhang
JCJianming Chen
Jianming Chen
Histone deacetylases (HDACs) are major epigenetic modulators involved in a broad spectrum of human diseases including cancers. As HDACs are promising targets of cancer therapy, it is important to understand the mechanisms of HDAC regulation. In this study, we show that ubiquitin-specific peptidase 4 (USP4) interacts directly with and deubiquitinates HDAC2, leading to the stabilization of HDAC2. Accumulation of HDAC2 in USP4-overexpression cells leads to compromised p53 acetylation as well as crippled p53 transcriptional activation, accumulation and apoptotic response upon DNA damage. Moreover, USP4 targets HDAC2 to downregulate tumor necrosis factor TNFα-induced nuclear factor (NF)-κB activation. Taken together, our study provides a novel insight into the ubiquitination and stability of HDAC2 and uncovers a previously unknown function of USP4 in cancers.

16 May 2017 in Natural Product Research
Verified
Journal Article
Closed access
WWWeiyi Wang
Weiyi Wang
RCRuixuan Chen
Ruixuan Chen
ZLZhuhua Luo
Zhuhua Luo
WWWei Wang
Wei Wang
JCJianming Chen
Jianming Chen
A novel anthraquinone, 2-(dimethoxymethyl)-1-hydroxyanthracene-9,10-dione (1), together with nine known compounds (2–10), were isolated from the fermentation of Aspergillus versicolor derived from deep sea sediment. Their structures were established through spectroscopic methods. Compound 1 exhibited strong inhibitory activities against MRSA ATCC 43300 and MRSA CGMCC 1.12409 (with MIC values of 3.9 and 7.8 μg/mL respectively) and moderate activities against tested strains of Vibrio (with MIC values ranging from 15.6 to 62.5 μg/mL). Compound 1 was subjected to molecular docking studies for inhibition of topoisomerase IV and AmpC β-lactamase enzymes indicating its usefulness as antimicrobial agent.

7 November 2017 in Marine Drugs
Verified
Journal Article
Open access
PDF file
WWWeiyi Wang
Weiyi Wang
YLYanyan Liao
Yanyan Liao
CTChao Tang
Chao Tang
XHXiaomei Huang
Xiaomei Huang
ZLZhuhua Luo
Zhuhua Luo
PCPeng Cai
Peng Cai
Three novel compounds, 4-methyl-candidusin A (1), aspetritone A (2) and aspetritone B (3), were obtained from the culture of a coral-derived fungus Aspergillus tritici SP2-8-1, together with fifteen known compounds (4–18). Their structures, including absolute configurations, were assigned based on NMR, MS, and time-dependent density functional theory (TD-DFT) ECD calculations. Compounds 2 and 5 exhibited better activities against methicillin-resistant strains of S. aureus (MRSA) ATCC 43300 and MRSA CGMCC 1.12409 than the positive control chloramphenicol. Compound 5 displayed stronger anti-MRSA and lower cytotoxic activities than 2, and showed stronger antibacterial activities against strains of Vibrio vulnificus, Vibrio rotiferianus, and Vibrio campbellii than the other compounds. Compounds 2 and 10 exhibited significantly stronger cytotoxic activities against human cancer cell lines HeLa, A549, and Hep G2 than the other compounds. Preliminary structure–activity relationship studies indicated that prenylation of terphenyllin or candidusin and the tetrahydrobenzene moiety in anthraquinone derivatives may influence their bioactivity.

1 January 2021 in Theranostics
Verified
Journal Article
Open access
SLShuxian Lu
Shuxian Lu
ZLZhaojie Lyu
Zhaojie Lyu
ZWZhihao Wang
Zhihao Wang
YKYao Kou
Yao Kou
CLCong Liu
Cong Liu
JTJing TIAN
Jing TIAN
Lipin 1 is an intracellular protein acting as a phosphatidic acid phosphohydrolase enzyme controlling lipid metabolism. Human recessive mutations in LPIN1 cause recurrent, early-onset myoglobinuria, a condition normally associated with muscle pain and weakness. Whether and how lipin 1 deficiency in humans leads to peripheral neuropathy is yet unclear. Herein, two novel compound heterozygous mutations in LPIN1 with neurological disorders, but no myoglobinuria were identified in an adult-onset syndromic myasthenia family. The present study sought to explore the pathogenic mechanism of LPIN1 in muscular and neural development.